Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipients.
Thompson EA, Ngecu W, Stoddart L, Johnston TS, Chang A, Cascino K, Alejo JL, Abedon AT, Samaha H, Rouphael N, Tobian AA, Segev DL, Werbel WA, Karaba AH, Blankson JN, Cox AL.
Thompson EA, et al. Among authors: karaba ah.
JCI Insight. 2023 May 22;8(10):e168470. doi: 10.1172/jci.insight.168470.
JCI Insight. 2023.
PMID: 37104041
Free PMC article.